EE200300002A - Perindopriili tert-butüülamiinsoola uudne kristalliline ß-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid - Google Patents

Perindopriili tert-butüülamiinsoola uudne kristalliline ß-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE200300002A
EE200300002A EEP200300002A EEP200300002A EE200300002A EE 200300002 A EE200300002 A EE 200300002A EE P200300002 A EEP200300002 A EE P200300002A EE P200300002 A EEP200300002 A EE P200300002A EE 200300002 A EE200300002 A EE 200300002A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
novel crystalline
butylamine salt
Prior art date
Application number
EEP200300002A
Other languages
English (en)
Inventor
Pfeiffer Bruno
Ginot Yves-Michel
Coquerel G�rard
Beilles St�phane
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of EE200300002A publication Critical patent/EE200300002A/et
Publication of EE05285B1 publication Critical patent/EE05285B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200300002A 2000-07-06 2001-07-06 Perindopriili tert-butlamiinsoola kristalliline β-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid EE05285B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008792A FR2811319B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002168 WO2001087836A1 (fr) 2000-07-06 2001-07-06 Nouvelle forme cristalline $g(b) du sel de tert-butylamine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
EE200300002A true EE200300002A (et) 2004-08-16
EE05285B1 EE05285B1 (et) 2010-04-15

Family

ID=8852171

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300002A EE05285B1 (et) 2000-07-06 2001-07-06 Perindopriili tert-butlamiinsoola kristalliline β-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid

Country Status (36)

Country Link
US (2) US20040029813A1 (et)
EP (2) EP1294689B1 (et)
JP (2) JP3592297B2 (et)
KR (1) KR100513571B1 (et)
CN (1) CN1328260C (et)
AP (1) AP1407A (et)
AR (1) AR029571A1 (et)
AT (1) ATE324367T1 (et)
AU (2) AU7641901A (et)
BG (1) BG66131B1 (et)
BR (1) BR0112244A (et)
CA (1) CA2415442C (et)
CZ (1) CZ301765B6 (et)
DE (1) DE60119107T2 (et)
DK (1) DK1294689T3 (et)
EA (1) EA004874B1 (et)
EE (1) EE05285B1 (et)
ES (1) ES2262666T3 (et)
FR (1) FR2811319B1 (et)
GE (1) GEP20043360B (et)
HK (1) HK1058200A1 (et)
HR (2) HRP20030079B8 (et)
HU (1) HU227673B1 (et)
ME (1) ME00440B (et)
MX (1) MXPA02012921A (et)
NO (1) NO323446B1 (et)
NZ (1) NZ523234A (et)
OA (1) OA12305A (et)
PL (1) PL348493A1 (et)
PT (1) PT1294689E (et)
RS (1) RS51717B (et)
SI (1) SI1294689T1 (et)
SK (1) SK286918B6 (et)
UA (1) UA57189C2 (et)
WO (1) WO2001087836A1 (et)
ZA (1) ZA200300024B (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
DK1636185T3 (da) 2003-06-24 2012-05-07 Servier Lab Nye krystalformer af Perindopril erbumin
ES2336554T3 (es) 2003-10-21 2010-04-14 Les Laboratoires Servier Nuevo metodo para la preparacion de perindopril erbumina cristalina.
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
HUE031058T2 (en) 2004-03-29 2017-06-28 Servier Lab A method of producing a solid pharmaceutical composition
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
US20090099370A1 (en) * 2005-08-12 2009-04-16 Sandoz Ag Crystalline Form of Perindopril Erbumine
EP1943267B1 (en) * 2005-08-12 2011-03-16 LEK Pharmaceuticals d.d. A process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2008050185A2 (en) * 2006-10-26 2008-05-02 Glenmark Pharmaceuticals Limited Novel polymorphs of perindopril erbumine
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
HUE025982T2 (en) * 2008-06-24 2016-05-30 Mylan Laboratories Ltd New polymorphic forms of perindopril (L) -arginine and a process for their preparation
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN106432042A (zh) * 2015-08-13 2017-02-22 南京华威医药科技开发有限公司 尼达尼布乙磺酸水合物的药物新晶型
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
RS51717B (sr) 2011-10-31
AP2002002710A0 (en) 2002-12-31
AR029571A1 (es) 2003-07-02
AU7641901A (en) 2001-11-26
HRP20030079B1 (en) 2007-12-31
US20050203165A1 (en) 2005-09-15
EP1294689B1 (fr) 2006-04-26
US7259181B2 (en) 2007-08-21
JP3592297B2 (ja) 2004-11-24
DE60119107T2 (de) 2006-12-07
NO20030050L (no) 2003-01-06
NO323446B1 (no) 2007-05-07
NO20030050D0 (no) 2003-01-06
NZ523234A (en) 2005-01-28
BG66131B1 (bg) 2011-06-30
JP2003533508A (ja) 2003-11-11
HU0102813D0 (en) 2001-09-28
SK286918B6 (sk) 2009-07-06
CZ301765B6 (cs) 2010-06-16
EA200300103A1 (ru) 2003-06-26
HRP20030079B8 (en) 2008-09-30
CA2415442A1 (fr) 2001-11-22
BG107533A (bg) 2003-11-28
SI1294689T1 (sl) 2006-08-31
DE60119107D1 (de) 2006-06-01
CN1328260C (zh) 2007-07-25
HK1058200A1 (en) 2004-05-07
HUP0102813A2 (hu) 2002-03-28
EE05285B1 (et) 2010-04-15
FR2811319A1 (fr) 2002-01-11
PT1294689E (pt) 2006-07-31
PL348493A1 (en) 2002-01-14
CN1440388A (zh) 2003-09-03
KR20030016368A (ko) 2003-02-26
KR100513571B1 (ko) 2005-09-09
FR2811319B1 (fr) 2002-08-23
HRP20030079A2 (en) 2003-04-30
HRP20060361A2 (en) 2008-06-30
AU2001276419B2 (en) 2006-11-16
US20040029813A1 (en) 2004-02-12
OA12305A (en) 2003-12-29
EP1294689A1 (fr) 2003-03-26
MXPA02012921A (es) 2004-07-30
ZA200300024B (en) 2004-02-05
EA004874B1 (ru) 2004-08-26
EP1676839A2 (fr) 2006-07-05
HU227673B1 (hu) 2011-11-28
CZ2003356A3 (cs) 2003-05-14
AP1407A (en) 2005-05-30
JP2005002121A (ja) 2005-01-06
UA57189C2 (uk) 2003-06-16
DK1294689T3 (da) 2006-08-28
ATE324367T1 (de) 2006-05-15
ES2262666T3 (es) 2006-12-01
ME00440B (me) 2011-10-10
CA2415442C (fr) 2009-01-27
SK1482003A3 (en) 2003-06-03
WO2001087836A1 (fr) 2001-11-22
BR0112244A (pt) 2003-06-24
GEP20043360B (en) 2004-06-10
EP1676839A3 (fr) 2006-11-08
HUP0102813A3 (en) 2003-12-29
YU100502A (sh) 2003-08-29
HRP20060361A8 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
EE200300002A (et) Perindopriili tert-butüülamiinsoola uudne kristalliline ß-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid
EE200300003A (et) Perindopriili tert-butüülamiinsoola kristallilinekamma-vorm, selle valmistamise protsess ning sedasisaldavad farmatseutilised kompositsioonid
EE05268B1 (et) Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid
AU2001276419A1 (en) Novel beta crystalline form of perindopril tert- butylamine salt, preparation method and pharmaceutical compositions containing same
AU2001276420A1 (en) Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200200409A (et) 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE05198B1 (et) Asendatud aminometlrhma sisaldavad N-(arlsulfonl)beetaaminohappe derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsi£onid
HUP0302519A3 (en) Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
EE200200655A (et) 5-kloro-3-(4-metaansulfonüülfenüül)-6'-metüül[2,3']bipüridinüüli polümorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0401499A3 (en) Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0402391A3 (en) Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it
EE200400022A (et) Pürrolidiinoksadiasooli ja -tiadiasooli derivaadid, nende valmistamise meetod ja neid sisaldavad ravimkoostised
EE200400018A (et) Gatifloksatsiini ja rasvhappe kristalne kopretsipitaat, selle valmistamise meetod ja seda sisaldav ravimkoostis
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0300248A3 (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors, process for their preparation and pharmaceutical compositions containing them
EE200400007A (et) Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
HUP0102815A3 (en) New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
EE200200528A (et) 2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
SG125974A1 (en) New beta crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125975A1 (en) New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20190706